RECENT NEWS
Benzinga  39 min ago  Comment 
Biotechnology stocks and exchange-traded funds are not off to good starts in 2016. That much is highlighted by the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB), the largest biotech ETF. Over the past month, IBB is lower by 23.2 percent...
SeekingAlpha  3 hrs ago  Comment 
newratings.com  5 hrs ago  Comment 
CANBERA (dpa-AFX) - Asian shares closed mostly higher on Friday after Wall Street stocks rebounded overnight, crude prices extended overnight gains and the safe-haven Japanese yen weakened in the wake of further BoJ easing. U.S. shares climbed...
Reuters  Jan 28  Comment 
Amgen Inc's fourth-quarter earnings soundly beat estimates on higher sales of its blockbuster rheumatoid arthritis drug Enbrel and lower costs, and the world's largest biotechnology company raised its 2016 profit forecast.
Motley Fool  Jan 28  Comment 
Some investors think the biotech is about to face some bad news.
Motley Fool  Jan 28  Comment 
Earnings releases aren't particularly useful when the biotech has already released preliminary numbers.
Wall Street Journal  Jan 28  Comment 
In a sharp departure from recent years, biotech stocks are underperforming the market. Investors might have to get used to that.
Yahoo  Jan 28  Comment 
U.S. stocks struggled for gains Thursday, as mixed earnings reports offset gains from a jump in oil prices.
FierceBiotech  Jan 28  Comment 
The French government is planning to triple the size of its biotech investment fund after the industry balked at the initial proposal. Officials now intend to hive off €340 million ($380 million) for the fund, more than three times the amount...
FierceBiotech  Jan 28  Comment 
Motif Bio has appointed an investment bank to look into raising cash in the U.S., potentially through an IPO on Nasdaq. The action was prompted by a desire to tap into the deep pool of capital managed by specialist biotech investors in the U.S.,...




RELATED WIKI ARTICLES

Related Articles

 
TOP CONTRIBUTORS

Biotechnology is the use of molecular biology and genetic engineering techniques to develop treatments for human diseases. Many leading companies from the industry originated in the late 70's from university research laboratories. In the 1980s after attracting venture investors and after listed in the US stock exchange,have then developed into a growing industry that uses research innovations to develop new agricultural products, biomedical tools, and human therapies such as monoclonal antibody for cancer. In 2006, 92% of employees in the biotechnology industry worked in companies that specialized in developing new drugs or medical devices and equipment, while 8% were employed in companies that specialized in agricultural products. [1] The large cap company in the group is Amgen, Genentech, Biogen-Idec, Genzyme. iShares Nasdaq Biotechnology (IBB) offers a low risk/reward investment vehicle for long term investors




Industry Information

Major Biotechnology Companies

ISTA Pharmaceuticals (ISTA)

Biotechnology Industry Trends & Forces

High Pipeline Risk for New Drugs

Dependence on Health Insurance/Medicare Coverage

Dependence on Governmental Regulations

High Volatility and Instability at Start-up

Litigation Risk

Market Share

References

  1. State Bioscience Initiatives 2008 Report, published by the Biotechnology Industry Organization

Top Ten/Twenty Best Selling Drugs 2009 http://knol.google.com/k/top-ten-twenty-best-selling-drugs-2009#

M&A Biotechnology http://knol.google.com/k/m-a-biotechnology#

http://knol.google.com/k/biotechnology-market-review-top-ten-biologics-2009#

Monoclonal Antibody Market 2009 http://knol.google.com/k/-/monoclonal-antibody-market-2009/3fy5eowy8suq3/86#

http://knol.google.com/k/new-drug-approvals-usa-fda-2009#

http://knol.google.com/k/new-drug-approvals-europe-ema-2009#

Vaccine Market 2009 http://knol.google.com/k/-/vaccine-market-2009/3fy5eowy8suq3/104#

Global Monoclonal Antibodies Market Review 2008 (World Top Ten mAbs) http://knol.google.com/k/global-monoclonal-antibodies-market-review-2008-world-top-ten-mabs#

M&A Review: Pharmaceutical & Biotechnology Industry http://knol.google.com/k/m-a-review-pharmaceutical-biotechnology-industry#

Global Vaccine Market Review 2008 (World Top Ten Vaccines) http://knol.google.com/k/global-vaccine-market-review-2008-world-top-ten-vaccines#


Ipilimumab (BMS) Review: A Cancer Breakthrough? http://knol.google.com/k/-/ipilimumab-bms-review-a-cancer/3fy5eowy8suq3/107#

Denosumab (Prolia, Amgen) FDA Review & Approval http://knol.google.com/k/-/denosumab-prolia-amgen-fda-review/3fy5eowy8suq3/60#

Companies in the Biotechnology Industry (193)

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki